John Libbey Eurotext

Epileptic Disorders

The Educational Journal of the International League Against Epilepsy

Sultiame revisited: treatment of refractory absence seizures Volume 18, numéro 3, September 2016

Illustrations

  • Figure 1
  • Figure 2
  • Figure 3

Tableaux

Auteurs
Department of Neurology and Clinical Neurophysiology, Temple Street Children's University Hospital, Dublin 1, Ireland
* Correspondence: Kathleen M. Gorman Department of Neurology and Clinical Neurophysiology, Temple Street Children's University Hospital, Dublin 1, Ireland
  • Mots-clés : sulthiame, absence seizure, refractory, idiopathic focal epilepsy, childhood absence epilepsy
  • DOI : 10.1684/epd.2016.0850
  • Page(s) : 329-33
  • Année de parution : 2016

Sultiame is recommended for the treatment of benign epilepsy of childhood with centrotemporal spikes, electrical status epilepticus during slow-wave sleep, as well as other genetic (idiopathic) focal epilepsies. Sultiame is not traditionally considered a treatment choice for idiopathic generalised epilepsy, and it does not appear on the list of drugs recommended for treatment of absence seizures. We report the efficacy of sultiame in treating three children with drug-resistant absence seizures and discuss the potential use of sultiame beyond the idiopathic focal epilepsies.